SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 5th, 2021 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 5, 2021 by and among X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”). For the avoidance of doubt, to the extent that only one Investor is identified on Exhibit A attached hereto, the term Investors as used herein shall refer only to the Investor identified on Exhibit A attached hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 5th, 2021 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Delaware
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 5, 2021 by and among X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of November 5, 2021 (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
